Navigation Links
Cyberonics Provides Update on Depression Post-Approval Study
Date:7/24/2009

"plan," "intend," and "forecast," or other similar words. Statements contained in this press release are based upon information presently available to us and assumptions that we believe to be reasonable. We are not assuming any duty to update this information should those facts change or should we no longer believe the assumptions to be reasonable. Investors are cautioned that all such statements involve risks and uncertainties, including without limitation, statements concerning completing follow-up on patients enrolled in the D-21 clinical study. Our actual results may differ materially. Important factors that may cause actual results to differ include, but are not limited to: continued market acceptance of VNS Therapy and sales of our product; the development and satisfactory completion of clinical trials and/or market test and/or regulatory approval of VNS Therapy for the treatment of other indications; satisfactory completion of post-market studies required by the U.S. Food and Drug Administration as a condition of approval for the treatment-resistant depression indication; adverse changes in coverage or reimbursement amounts by third-parties; intellectual property protection and potential infringement claims; maintaining compliance with government regulations and obtaining necessary government approvals for new indications; product liability claims and potential litigation; reliance on single suppliers and manufacturers for certain components; the accuracy of management's estimates of future expenses and sales; the results of the previously disclosed governmental inquiries; the potential identification of material weaknesses in our internal controls over financial reporting; risks and costs associated with such governmental inquiries and any litigation relating thereto and other risks detailed from time to time in our filings with the Securities and Exchange Commission (SEC). For a detailed discussion of these and other cautionary statements, please refe
'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Raptor Pharmaceuticals Provides Update of Product Programs
5. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
6. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
7. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Treatment with PEGASYS(R)/COPEGUS(TM) Provides Hope for Hepatitis C Patients Whose Infection Did Not Initially Respond to Peg-Intron(R)/Ribavirin
11. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 4, 2015 Concord Medical Services Holdings Limited ... hospital management solution provider and operator of the largest network ... , today announced it will release its financial results ... on August 17, 2015. Management will hold a ... 8:00 a.m. EDT on August 18, 2015 (8:00 p.m. in ...
(Date:8/4/2015)... 2015 BioElectronics Corporation (OTC Pink: BIEL), ... Therapy medical devices, announced today that its registry ... trial device has been published in the prominent ... http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 chronic pain ... assessment.  Chronic pain is a ...
(Date:8/4/2015)... 2015 Research and ... of Jain PharmaBiotech,s new report "Animal Biotechnology ... offering. This report describes and evaluates ... and pharmaceuticals as well as improvement in food ... the application of biotechnology to manage genetic disorders ...
Breaking Medicine Technology:Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3
... 10, 2012  - Agreement allows development ... plc (LSE: SHP, NASDAQ: SHPGY ), the ... acquired the rights to develop and market Resolor ® ... agreement  with Janssen Pharmaceutica N.V.  Terms of the agreement ...
... RATON, Fla., Jan. 10, 2012   MX.com today ... Solution designed to help healthcare administrators add new hospital ... by Rush University Medical Center, the program integrates treatment ... 2004, it has grown by 900 percent and demand ...
Cached Medicine Technology:Shire Acquires US Rights to Resolor(R) (prucalopride) 2Shire Acquires US Rights to Resolor(R) (prucalopride) 3Shire Acquires US Rights to Resolor(R) (prucalopride) 4MX.com Launches Pelvic Health Program Model to Help Hospitals Rapidly Expand Key Services 2
(Date:8/5/2015)... ... ... What language does a body speak? "Body Language – from Head to ... that contain the name of a body part. , The use of body part-related ... words, and expressions, for example, “back against the wall,” “brainstorming,” “sweet tooth,” and “tongue ...
(Date:8/5/2015)... ... August 05, 2015 , ... A leader in Primary Care Continuing ... that it has hired Su Barnwell as its new Director of Program Management. , ... 1999 to 2015 she worked for Primary Care Network (PCN) as the Director, Program ...
(Date:8/5/2015)... ... August 05, 2015 , ... It is exciting ... of global organisations such as PhUSE or CDISC are currently bringing in the ... the Japanese PMDA and the European EMA. A move towards global harmonisation of ...
(Date:8/4/2015)... , ... August 05, 2015 , ... ... Deborah Stevens as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting more ...
(Date:8/4/2015)... ... August 04, 2015 , ... Sponsored by Gila River Casinos, the charity event ... nonprofit organization. , According to the New Foundation AZ spokesperson , the organization ... that includes a complimentary foursome for the tournament, as well as getting their company ...
Breaking Medicine News(10 mins):Health News:Harvard Medical Professor Dr. Per-Olof Hasselgren Pens Unique Book Using Body Part Idioms 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 3Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 2Health News:Japan PMDA Publishes English Versions of Electronic Data Submission & Technical Conformance Guidance 3Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3
... MD Who Signed Prop 8 Ballot Argument, SACRAMENTO, ... campaign,today released a statement signed by more than 300 ... and concluding,that the physician who signed the Prop 8 ... majority of pediatricians on this issue., The pediatrician ...
... Long after a conflict, landmines remain buried underground unless someone ... (UN), there are more than 100 million landmines buried in ... more than 2,000 people are killed or injured by landmine ... working to enhance the accuracy of a landmine radar system ...
... genome in the hope of ,finding genetic variants responsible ... wrong place, new research at the Stanford ,University School ... type-1 diabetes, is an autoimmune ,disease, caused when the ... person,s pancreas. , What triggers that immune response apparently ...
... American Society,for Therapeutic Radiology and Oncology welcomed 12,487 people ... the Boston Convention and,Exhibition Center and featured 114,200 net ... 4,900 square feet increase over last year, respectively.,Both the ... highs for an ASTRO Annual Meeting., This year,s ...
... November 5, 2008 at 11:00 a.m.,ET -, LOUISVILLE, Ky., ... leading regional provider of home health nursing,services, announced today that ... 30, 2008 on Wednesday, November 5, 2008, before the,market open., ... at 11:00 a.m. ET on,November 5, 2008 and will be ...
... ST. PAUL, Minn., Oct. 30 Image Sensing,Systems, Inc. ... for the,third quarter ended September 30, 2008., (Logo: ... ended September 30, 2008 was $1.2 million,($0.29 per fully ... share) for the same period in 2007. Net income ...
Cached Medicine News:Health News:NO on Prop 8 Campaign Releases Statement by 300 California Pediatricians 2Health News:Engineer creating more sensitive, safer landmine detectors 2Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 2Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 3Health News:Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows 4Health News:Premier Radiation Oncology Meeting Breaks Attendance, Exhibit Space Record at Boston Meeting 2Health News:Almost Family, Inc. to Report Third Quarter 2008 Financial Results 2Health News:Image Sensing Systems Announces Third Quarter Financial Results 2Health News:Image Sensing Systems Announces Third Quarter Financial Results 3Health News:Image Sensing Systems Announces Third Quarter Financial Results 4Health News:Image Sensing Systems Announces Third Quarter Financial Results 5Health News:Image Sensing Systems Announces Third Quarter Financial Results 6Health News:Image Sensing Systems Announces Third Quarter Financial Results 7Health News:Image Sensing Systems Announces Third Quarter Financial Results 8Health News:Image Sensing Systems Announces Third Quarter Financial Results 9
... special order products are offered as 1-piece ... lengths. The modular instruments may be customized ... such as ratchets, insulation and flush ports. ... stock. Customer specifications may affect delivery times. ...
... Many special order products are offered ... extra long lengths. The modular instruments may ... other options such as ratchets, insulation and ... from Mediflex stock. Customer specifications may affect ...
... order products are offered as 1-piece or ... The modular instruments may be customized with ... as ratchets, insulation and flush ports. Many ... Customer specifications may affect delivery times. ...
... are offered as 1-piece or modular, in ... instruments may be customized with handles of ... insulation and flush ports. Many standard patterns ... may affect delivery times. , Please ...
Medicine Products: